Introduction
Chronic Kidney Disease (CKD) Drugs Market was valued at USD XX Billion in 2019 and is projected to reach USD XX billion by 2025, at a CAGR of XX% from 2020-2025. Due to rise in the incidents of chronic kidney diseases, increasing prevalence of diabetes & metabolic conditions, increasing geriatric population Chronic Kidney Disease Drug Market is witnessing a good growth. Additionally, important unmet requirements, reimbursement policies, increasing cardiovascular diseases are also major driving factors for the Chronic Kidney Disease (CKD) Drugs Market.
On the other hand, cut-throat competition from biosimilars and rising preference of generic drugs, are some of the restraining factor this Market.
Geographical Overview
At a global level, the North America region was holding the highest market share in 2019, due to growing R&D activities and presence of key players. Whereas, Asia Pacific region is considered the fastest-growing region with key players adopting expansion strategy in this region to gain maximum market share in the coming years. Key factors such as increasing patients with kidney related diseases, rising awareness regarding these renal disorders among them are driving Chronic Kidney Disease (CKD) Drugs Market in the Asia Pacific region.
?
Segmental Overview
Chronic Kidney Disease (CKD) Drugs Market is segmented as per below specifications -
By Drug Class Type:
• ACE Inhibitors
• Angiotensin-II Receptor Blockers
• Calcium Channel Blockers
• Beta Blockers
• Erythropoiesis-Stimulating Agents (ESAs)
• Diuretics
By End User Type:
• Hospitals
• Specialty Clinics
Competitor Analysis
Chronic Kidney Disease (CKD) Drugs Market has presence of some of the key major players across globe which includes
• AbbVie Inc.
• Amgen Inc.
• GlaxoSmithKline PLC
• F. Hoffmann-La Roche Ltd.
• AstraZeneca PLC
• Pfizer Inc.
• Sanofi
• Teva Pharmaceutical Industries Ltd.
• Johnson & Johnson
• FibroGen Inc.
• Akebia Therapeutics, Inc.
These key players are concentrating its efforts on the continuous product improvement with innovative initiatives to have an edge over other competitors. Further, to garner maximum market share, companies are adopting merger/ acquisition/ partnership and maintaining strong distribution networks strategies.
By Geographical Locations:
• North America
o U.S.
o Canada
• Europe
o U.K.
o France
o Italy
o Germany
o Spain
o Russia & CIS
o Rest of Europe
• Asia-Pacific
o China
o India
o Japan
o South Korea
o ASEAN
o Rest of Asia Pacific
• Latin America
o Brazil
o Argentina
o Rest of LATAM
• Middle East & Africa
o UAE
o South Africa
o Rest of MEA
Highlights of the report
What is Chronic Kidney Disease (CKD) Drugs Market?
Who all are key market players in the industry?
How the Parent Industry is growing?
Where are the key opportunities for new market entrant?
A comprehensive analysis, which covers key growth factors across the value chain
Recent developments in market
Granular Market Segmentation
Market size projection based on Historical & current market trends
Market share analysis and key strategies adopted by leading players
Production Cost & Sensitivity Analysis
Country Level Market Analysis of Top 16 countries
Data Driven Decision Recommendations
?
Chapter 1 Research Objective
1.1 Need of the Research Report
1.2 Client Objectives
1.3 Offered Solutions
Chapter 2 Recommendations
2.1 Executive Summary
2.1.1 Market Overview
2.1.2 Competitive Insights
2.1.3 Segmental Analysis
2.1.4 Geographical Market Details
2.2 Lead Generation
2.3 Consultant
2.4 Return on Investment
Chapter 3 Research Methodology
3.1 Chromatus Database
3.2 Paid Sources
3.3 Primary Data Collection
3.3.1 Email Surveys
3.3.2 Telephonic Interviews
3.3.3 Face to Face Interviews
3.4 Secondary Data Collection
3.4.1 Annual Reports
3.4.2 Government Publications
3.4.3 Trade Data
3.4.4 Association Data
3.4.5 Research Papers/ Blogs/ News Articles
3.5 Expert Advisory Panel
3.6 Data Analytics Model
Chapter 4 Chronic Kidney Disease (CKD) Drugs Market Overview
4.1 Parent Market Overview
4.2 Patent Analysis
4.3 PESTEL Analysis
4.3.1 Political
4.3.2 Economical
4.3.3 Social
4.3.4 Technological
4.3.5 Legal
4.4 SWOT Analysis
4.4.1 Strengths
4.4.2 Weakness
4.4.3 Opportunities
4.4.4 Threats
4.5 Regulations
4.6 Value Chain/ Supply Chain Analysis
4.7 Procurement & Vendor Analysis
4.8 Porters Five Analysis
4.8.1 Threat of new entrants
4.8.2 Bargaining power of suppliers
4.8.3 Bargaining power of buyers
4.8.4 Threat of substitutes
4.8.5 Competitive rivalry
Chapter 5 Regional Analysis
Global Chronic Kidney Disease (CKD) Drugs Market Estimation and Forecast, 2019 - 2025 (USD Billion)
5.1 North America Market
5.1.1 U.S.
5.1.1 Canada
5.2 Europe Market
5.2.1 UK
5.2.2 Germany
5.2.3 France
5.2.4 Spain
5.2.5 Italy
5.2.6 Russia & CIS
5.2.7 Rest of Europe
5.3 Asia Pacific Market
5.3.1 China
5.3.2 Japan
5.3.3 India
5.3.4 South Korea
5.3.5 ASEAN
5.3.6 Rest of Asia Pacific
5.4 Rest of the World
5.4.1 Latin America
5.4.1.1 Brazil
5.4.1.2 Argentina
5.4.1.3 Rest of Latin America
5.4.2 Middle East
5.4.3 Africa
Chapter 6 Company Profile
6.1 AbbVie Inc.
6.1.1 Introduction
6.1.2 Financial Overview
6.1.3 Product Portfolio
6.1.4 Recent Developments
6.1.5 SWOT Analysis
6.2 Amgen Inc.
6.3 GlaxoSmithKline PLC
6.4 F. Hoffmann-La Roche Ltd.
6.5 AstraZeneca PLC
6.6 Pfizer Inc.
6.7 Sanofi
6.8 Teva Pharmaceutical Industries Ltd.
6.9 Johnson & Johnson
6.10 FibroGen Inc.
6.11 Akebia Therapeutics, Inc.
Chapter 7 Competitor Analysis
7.1 Company Ranking
7.2 Key Innovators
7.3 Market Leader
7.4 Emerging Players
7.5 Strategic Alliances
7.6 Competitive Matrix of 11 Companies
Chapter 8 Global Chronic Kidney Disease (CKD) Drugs Market by Drug Class Type Estimation and Forecast, 2019 - 2025 (USD Billion)
8.1 ACE Inhibitors
8.2 Angiotensin-II Receptor Blockers
8.3 Calcium Channel Blockers
8.4 Beta Blockers
8.5 Erythropoiesis-Stimulating Agents (ESAs)
8.6 Diuretics
Chapter 9 Global Chronic Kidney Disease (CKD) Drugs Market by End User Type Estimation and Forecast, 2019 - 2025 (USD Billion)
9.1 Hospitals
9.2 Specialty Clinics
Chapter 10 Appendix
10.1 Data Sources
10.2 Abbreviations
10.3 About US
10.4 Disclaimer
10.5 Key Notes
List of Tables
Table 1 Global Chronic Kidney Disease (CKD) Drugs Market, by Region, 2019 - 2025 (USD Billion)
Table 2 Global Chronic Kidney Disease (CKD) Drugs Market, by Drug Class Type, 2019 - 2025 (USD Billion)
Table 3 Global Chronic Kidney Disease (CKD) Drugs Market, by End User Type, 2019 - 2025 (USD Billion)
Table 4 Global Chronic Kidney Disease (CKD) Drugs Market, by Distribution Type, 2019 - 2025 (USD Billion)
Table 5 North America Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 6 North America Chronic Kidney Disease (CKD) Drugs Market by Drug Class Type 2019 - 2025 (USD Billion)
Table 7 North America Chronic Kidney Disease (CKD) Drugs Market by End User Type 2019 - 2025 (USD Billion)
Table 8 North America Chronic Kidney Disease (CKD) Drugs Market by Distribution Type 2019 - 2025 (USD Billion)
Table 9 US Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 10 Canada Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 11 Europe Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 12 Europe Chronic Kidney Disease (CKD) Drugs Market by Drug Class Type 2019 - 2025 (USD Billion)
Table 13 Europe Chronic Kidney Disease (CKD) Drugs Market by End User Type 2019 - 2025 (USD Billion)
Table 14 Europe Chronic Kidney Disease (CKD) Drugs Market by Distribution Type 2019 - 2025 (USD Billion)
Table 15 UK Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 16 Germany Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 17 France Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 18 Spain Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 19 Italy Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 20 Russia & CIS Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 21 Rest of Europe Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 22 Asia Pacific Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 23 Asia Pacific Chronic Kidney Disease (CKD) Drugs Market by Drug Class Type 2019 - 2025 (USD Billion)
Table 24 Asia Pacific Chronic Kidney Disease (CKD) Drugs Market by End User Type 2019 - 2025 (USD Billion)
Table 25 Asia Pacific Chronic Kidney Disease (CKD) Drugs Market by Distribution Type 2019 - 2025 (USD Billion)
Table 26 China Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 27 Japan Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 28 India Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 29 South Korea Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 30 ASEAN Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 31 Rest of Asia Pacific Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 32 Latin America Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 33 Latin America Chronic Kidney Disease (CKD) Drugs Market by Drug Class Type 2019 - 2025 (USD Billion)
Table 34 Latin America Chronic Kidney Disease (CKD) Drugs Market by End User Type 2019 - 2025 (USD Billion)
Table 35 Latin America Chronic Kidney Disease (CKD) Drugs Market by Distribution Type 2019 - 2025 (USD Billion)
Table 36 Brazil Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 37 Argentina Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 38 Rest of Latin America Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 39 Middle East Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 40 Middle East Chronic Kidney Disease (CKD) Drugs Market by Drug Class Type 2019 - 2025 (USD Billion)
Table 41 Middle East Chronic Kidney Disease (CKD) Drugs Market by End User Type 2019 - 2025 (USD Billion)
Table 42 Middle East Chronic Kidney Disease (CKD) Drugs Market by Distribution Type 2019 - 2025 (USD Billion)
Table 43 Africa Chronic Kidney Disease (CKD) Drugs Market 2019 - 2025 (USD Billion)
Table 44 Africa Chronic Kidney Disease (CKD) Drugs Market by Drug Class Type 2019 - 2025 (USD Billion)
Table 45 Africa Chronic Kidney Disease (CKD) Drugs Market by End User Type 2019 - 2025 (USD Billion)
Table 46 Africa Chronic Kidney Disease (CKD) Drugs Market by Distribution Type 2019 - 2025 (USD Billion)
List of Figures
Fig. 1 Primary Research Method
Fig. 2 Secondary Research Method
Fig. 3 Value chain analysis
Fig. 4 PESTEL Analysis
Fig. 5 SWOT Analysis
Fig. 6 Porters Five forces analysis
Fig. 7 Chronic Kidney Disease (CKD) Drugs Market: Penetration & growth prospect mapping
Fig. 8 Chronic Kidney Disease (CKD) Drugs Market: Competitive snapshot
Fig. 9 Chronic Kidney Disease (CKD) Drugs Market: Segmental snapshot
Fig. 10 Market Overview
Fig. 11 Chronic Kidney Disease (CKD) Drugs Market: Product Analysis, 2019 - 2025
Fig. 12 Chronic Kidney Disease (CKD) Drugs Market: Regional Analysis, 2019 - 2025
Fig. 13 Chronic Kidney Disease (CKD) Drugs Market: Competitive Matrix
Fig. 14 Chronic Kidney Disease (CKD) Drugs Market: Revenue Mix